about
Age-related neuroinflammatory changes negatively impact on neuronal functionTransthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis ProjectChondroitin sulfate proteoglycans in the nervous system: inhibitors to repairOxidative Stress Signaling in Alzheimers DiseaseVariant of TREM2 Associated with the Risk of Alzheimer's DiseaseA common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degenerationMyD88 deficiency ameliorates β-amyloidosis in an animal model of Alzheimer's diseaseThe role of macrophage migration inhibitory factor in Alzheimer's diseaseNeuroprotective and disease-modifying effects of the ketogenic dietBiomarkers of Alzheimer's diseaseSignaling effect of amyloid-beta(42) on the processing of AbetaPPReduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptorNSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivoTNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot studyInduction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic miceInnate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcuminGlycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeuticsDifferential regulation of Abeta42-induced neuronal C1q synthesis and microglial activationBrain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosisWelcome to the Journal of Neuroinflammation!Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptideUsing animal models to determine the significance of complement activation in Alzheimer's diseaseChronic brain inflammation leads to a decline in hippocampal NMDA-R1 receptorsModelling neuroinflammatory phenotypes in vivoMicroglia and neuroinflammation: a pathological perspectivePlatelet-activating factor enhancement of calcium influx and interleukin-6 expression, but not production, in human microglia.Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice.Heparan sulfate proteoglycan induces the production of NO and TNF-alpha by murine microglia.The microglial "activation" continuum: from innate to adaptive responsesInnate immunity and inflammation in ageing: a key for understanding age-related diseases5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) attenuates the expression of LPS- and Abeta peptide-induced inflammatory mediators in astroglia.Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's diseaseInterleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human beta-amyloid.Neuroprotective Activity of Hypericum perforatum and Its Major ComponentsResolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancerTargeting innate immunity for neurodegenerative disorders of the central nervous systemThe Rationale for Insulin Therapy in Alzheimer's DiseaseIntracellular Calcium Dysregulation: Implications for Alzheimer's DiseaseFundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats
P2860
Q21128630-DE5661CB-3FE2-4D5F-BE67-DAD2E70F79D6Q21202832-1FBBED72-E412-479E-9770-51E3E5300263Q21261508-095EAFD5-E051-4ABF-8F82-B1A5BB8D5158Q21284516-50C9496B-CA58-4BCC-89CB-8E0EFC0D8E73Q22241327-E0D644BD-3B7D-4747-8A7A-F5FBD3036D20Q22250874-2D761B46-153E-45D3-94A1-61E842650D9AQ24523983-52F40FE9-6A6D-42AE-932E-AA2D517D1DC8Q24616286-4DA7E48F-9978-4638-98F1-514FA0BD1BDAQ24634765-F14A85AC-5127-4506-9274-6B02EA79C816Q24646914-21B766F8-86AC-40E2-B7D4-6E1FC4689325Q24650667-DF8FECD8-3F58-4B0E-9124-75D3F725E7D1Q24656147-179795A4-5708-45F6-91C0-4A62EBE19155Q24672600-CE8B888E-A2D2-4FD1-AEB3-602487E54873Q24679444-FC35B603-27D5-4A70-A79B-CFA5683270D6Q24681139-D263378F-5ABE-4809-8215-AFEFC318F1C4Q24681736-C5A357E5-9466-412A-949F-07FDE7AEE3B0Q24682639-4685B9AC-C01C-480D-BBAF-A5C96F7506BBQ24685475-F42B9F59-CCB8-4C2E-940D-663B8822228EQ24791689-5A067D62-D8FB-40E0-9EFE-6C9F78EEE652Q24793976-EA7F739E-F159-4535-8DD0-DC43E21B3BC0Q24794327-8E9FA4E9-BC15-464A-B502-D0D547A1B31BQ24794350-84B57495-E87D-4F73-A856-58CF6E300883Q24796236-BEC3FD55-867B-4A99-94C7-8F40FDE2BF01Q24796326-AF57C73B-82BE-49C3-B7A2-9340C7D54C52Q24796385-D999AEAE-E151-490F-8DEB-2A7C4BF970ADQ24799838-42DF3633-1690-4E1D-A9F5-495B1F4F39B8Q24802345-D5B1DB85-4658-4810-9439-ECF2A166E151Q24812365-A7DF3BD9-B52A-4B07-9F38-9E2345C2E12DQ24813947-F5B109D9-6A09-4DAA-B61F-3069730D09D7Q24814335-76747E98-2DB1-497F-B7EE-7515482ADB52Q24814846-68F619C7-C736-46B1-8776-A01770F15004Q24815455-979BA773-A3E0-4345-9B9A-736DCD835263Q24815590-785D4FA0-BB56-40C8-AA0B-5355A9EA39FBQ24815721-736117FC-8E78-4871-AC48-5488C4B61B0AQ26741405-AC4636E3-3216-4F2C-9F24-80C4423E6458Q26741524-6E1C8394-B23E-4BE1-A852-C0FE7F5CCAF3Q26744219-3F930E4A-319B-4A2F-90A0-61B1FF17F3C3Q26744834-AA3DA51A-35A3-4BC0-948F-181DF5466704Q26747203-FEEA0D24-BB5C-4BC6-9B04-7A2BD5873AF4Q26747585-FFBFF47D-E1A6-4F1B-BBA0-040ACA743A87
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականին հրատարակուած գիտական յօդուած
@hyw
2000 թվականին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Inflammation and Alzheimer's disease
@ast
Inflammation and Alzheimer's disease
@en
Inflammation and Alzheimer's disease
@nl
type
label
Inflammation and Alzheimer's disease
@ast
Inflammation and Alzheimer's disease
@en
Inflammation and Alzheimer's disease
@nl
prefLabel
Inflammation and Alzheimer's disease
@ast
Inflammation and Alzheimer's disease
@en
Inflammation and Alzheimer's disease
@nl
P2093
P2860
P3181
P1476
Inflammation and Alzheimer's disease
@en
P2093
B L Fiebich
B Wegrzyniak
C Plata-Salaman
F L Van Muiswinkel
G Landreth
G Pasinetti
P2860
P304
P3181
P356
10.1016/S0197-4580(00)00124-X
P407
P50
P577
2000-01-01T00:00:00Z